Regencell Bioscience (RGC) had the highest return in Q1 2025 by a large-cap US stock, returning 527.9%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | Q1 2025 | 527.92% |
Xpeng (XPEV) | Q1 2025 | 79.08% |
Harmony Gold Mining (HMY) | Q1 2025 | 75.42% |
Gold Fields Ltd ADR (GFI) | Q1 2025 | 63.14% |
AngloGold Ashanti (AU) | Q1 2025 | 59.89% |
Alibaba (BABA) | Q1 2025 | 56.69% |
Grupo Cibest (CIB) | Q1 2025 | 53.32% |
CVS Health (CVS) | Q1 2025 | 52.1% |
Banco Santander SA ADR (SAN) | Q1 2025 | 49.89% |
BeiGene (ONC) | Q1 2025 | 49.13% |
Elbit Systems (ESLT) | Q1 2025 | 46.12% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | Q1 2025 | 44.13% |
Alamos Gold (AGI) | Q1 2025 | 42.99% |
Lloyds Banking Group PLC ADR (LYG) | Q1 2025 | 41.48% |
Deutsche Bank (DB) | Q1 2025 | 38.55% |
Prudential PLC ADR (PUK) | Q1 2025 | 37.52% |
Agnico Eagle Mines (AEM) | Q1 2025 | 37.11% |
Guardant Health (GH) | Q1 2025 | 36.32% |
Sandisk (SNDK) | Q1 2025 | 35.8% |
Wheaton Precious Metals (WPM) | Q1 2025 | 35.6% |
TIM Participacoes (TIMB) | Q1 2025 | 35.22% |
Kinross Gold (KGC) | Q1 2025 | 34.8% |
Equinox Gold (EQX) | Q1 2025 | 34.11% |
Franco-Nevada (FNV) | Q1 2025 | 32.58% |
Philip Morris International (PM) | Q1 2025 | 31.97% |
Large-cap stocks are treated as having a market cap of $10B+.
